Ms. Karin Gregory, General Partner









Ms. Gregory’s expertise spans over 30 years in healthcare and related technologies, as a business advisor,  C level executive, venture capitalist, scientist  and lawyer. Her legal practice has focused on science based bioscience companies including, medtech, health care, health food and nutritional supplement companies on all aspects of the business beyond the corporate and finance side to  include the regulatory  compliance, advertising and promotion of these types of businesses. She has years of private equity experience in the quasi-public and private sectors.

 Ms. Gregory joined Massachusetts Technology Development Corporation (MTDC) now Mass Ventures, where she led medical investing efforts for five years; she then left to form Dover Medical Ventures, a medical technology-focused consulting and venture capital firm. In 2006, Furman Gregory LLC, boutique business law firm was formed. She has advised Kimberly Clark’s venture capital fund on medical technology and has been a member of two angel investment groups in New England for the past 10 years.  Though Ms. Gregory’s legal, regulatory and venture capital expertise along with the ability to  leverage her financial and entrepreneurial networks, will help to find the best projects for CTM and to enhance the potential for the CTM portfolio.

Ms. Gregory is a frequent presenter on venture capital fundraising, start-up legal issues, and food and medical device labeling, advertising and promotion issues.  Ms. Gregory holds a JD from UNH School of Law, a Master in Public Health (MPH) with a concentration in Health Services Management from Boston University and a BA in Bio-Psychology from Wells College. She is admitted to practice law in Massachusetts and Maine. Karin serves on several non-profit and for –profit boards.


Michael Wing, General Partner









Mr. Wing has 25 years of management experience directing, managing and consulting with manufacturing and management operations in high-tech industries. Mike has a deep background in the re-design of manufacturing operations and  turn-around projects for manufacturing  operations, including new product manufacturing launch, factory re-design, staffing and training and re-engineering all aspects of operations. He has experience with both the strategic and tactical aspects of business and has considerable experience in creating lean and productive operations, leading change, managing growth and recruiting talent.

Mike also has significant experience designing, developing and executing experiential education programs of distinction for programs in Science, Technology, Engineering and Math (STEM) including research, development and commercialization programs for inventors, entrepreneurs, small companies and faculty as well as a full scale experiential learning program for internships, co-ops and honors programs for talented STEM students.


He holds an MBA with a concentration in Operations Management from the Whittimore School of Business and Economics at the University of New Hampshire as well as a B.S. in Industrial Management from the University of Southern Maine and a degree in Machine Tooling.  Mr. Wing is an advisor and director on several non-profit and private boards.


Ron Metro, General Partner










Mr. Metro has over 25 years of sales and marketing leadership experience in the medical device industry with early stage pre-IPO and fortune 500 businesses specializing in product technologies across multiple medical specialties, including interventional cardiovascular and endovascular, vascular access, and minimally invasive general, orthopedic, urology & GYN surgery.  Mr. Metro has built and/or managed sales and marketing organizations in successful companies, start-ups, and start-up divisions within much larger organizations.

He spent his early years at Cordis Corporation, which was acquired by Johnson & Johnson after its growth from $10M-$350M. Subsequent to Cordis, Mr. Metro held senior sales leadership roles with ACMI Corporation (acquired by Olympus Corporation), Edwards Lifesciences’ interventional peripheral start-up division (acquired by CR Bard), and Kensey Nash Corporation’s interventional cardio & endovascular division (acquired by Spectranetics Corp).  Prior to his tenure at ACMI, he served as President and CEO of an early stage venture funded start-up, Visionscope, Inc., (unique office based arthroscopy platform) where he led the company from development of the initial Business Plan through funding, technical proof-of-concept, and through pre-clinical stages.

Ron holds an MBA from the Sawyer School of Business at Suffolk University in Boston and a BA in Management with a concentration in Marketing from the University of Massachusetts..


CTM Advisors

David L. Anderson







Dr. Anderson is Managing Director of Supply Chain Ventures, LLC, a venture capital and consulting company specializing in marketing, sales and supply chain software investing. He is a retired managing partner of supply chain consulting at Accenture, a global technology consulting company.

He serves on the Board of Directors of Descartes Systems Group, of Waterloo, Ontario, Steelwedge Software , of Pleasanton, California,  Aiko Biotechnology, a Portland, Maine drug development company, Placester of Boston, Massachusetts, NBD Nanotechnology of Boston, Massachusetts and is Board Chairman of Control Group, a New York City-based digital media technology consulting company.


He is also Chairman of the Board of Trustees of the University of New England and a member of the Boston College Technology Council.

Dr. Anderson received his Doctor of Philosophy Degree in Econometrics and Finance from Boston College and his Bachelor of Arts Degree in Economics from the University of Connecticut.

 

Jean-Luc Boulnois, Ph.D.






 

Jean-Luc G. Boulnois has 30 years of international experience in the medical technology industry, where he has developed early-stage companies, participated in an Initial Public Offering (IPO), and led licensing agreements, mergers and acquisitions. Dr. Boulnois’ focus has been on fast growth opportunities, either through innovation or strategic expansion.

Since 2004, Dr. Boulnois has been Chairman and Chief Executive Officer of Microline Surgical. In 2013, he was appointed Microline’s Executive Chairman. In this role Dr. Boulnois is focused on the company’s long-term strategic objectives, while creating and developing partnerships that complement Microline’s core business and enhance shareholder value.

Prior to Microline, Dr. Boulnois served as Executive Director of New Technology at Arrow International (Nasdaq: ARRO), where, as part of the Global Business Development Group in charge of Mergers and Acquisitions, he managed the technology and market assessment team.

Dr. Boulnois was previously Co-founder, President and CEO of Sometec, an innovative international medical device company in the field of non-invasive cardiovascular monitoring. Prior to Sometec, Dr. Boulnois was President and COO of Technomed International Inc., a medical company specializing in non-invasive ultrasound and laser technologies for kidney stone treatment, for which he obtained several FDA approvals and achieved 60 percent growth in two years. He participated in the IPO of the Technomed International group on the Paris Stock Exchange.

Dr. Boulnois also held various positions at Quantel SA, a French company where he developed scientific and medical lasers, and its California parent company Quantel International.

Dr. Boulnois serves on the Advisory Council of the Mechanical and Aerospace Engineering Department of Princeton University, and on the Board of Directors of Fiber Optic Company, an early-stage fiber-based products company. He also serves on the Board of Directors of Mauna Kea Technologies, a global medical device company dedicated to the advent of optical biopsy. For the last 11 years, Dr. Boulnois has also been Adjunct Professor in Entrepreneurship at the Arthur M. Blank Center for Entrepreneurship at Babson College, Mass.

Dr. Boulnois is co-author of five books and more than 40 scientific articles in applied physics and biophysics. His educational achievements include: Engineering Degree, Ecole Superieure des Techniques Automobiles et des Constructions Aeronautiques, France; M.Sc. Centre d’Etudes Superieures de Mecanique, Paris University, France; E.M.B.A., HEC-Centre de Perfectionnement aux Affaires, France; M.A. and Ph.D. in Aerospace Engineering, Applied Physics Group, Princeton University.


Dr. Boulnois is bi-national American and French, and has lived for 26 years in the United States

 
Claire Deselle 









Claire Deselle is currently the Director of Innovation Development at Eastern Maine Healthcare Systems.  She is leading the design, development and implementation of a structured Innovation Research & Development framework tasked with positively impact care delivery.  Previously, she has had a number of leadership roles including the Executive Director of the Bioscience Association of Maine which is a trade association for biotech, medical device and related industries,  Chief Operating Officer for the Maine Institute for Human Genetics and Health, a non-profit research entity,   President and CEO of CS-Keys Inc., a biotech company developing cancer diagnostics and therapeutics,  and more than 14 years with Eli Lilly and Company  in various management assignments.   She earned a BSc from the University of New Hampshire and an MBA from the Wharton School at the University of Pennsylvania.

 Kerem Durdag










Born and raised in Pakistan of Turkish parents, fortunate enough to be educated in a British school and then completing undergraduate and graduate studies in the US, Mr. Durdag is a member of his peer group of technology executives.  He is Chief Executive Officer for Biovation (www.biovation.com), and also currently a partner of a small private equity firm BlueWave Investments while also being a member of the Maine Angels investor community (www.maineangels.org).  Previously he was the Director of Sales and Marketing of SenGenuity, a division of Vectron International responsible for global sales, marketing and product management initiatives. Prior to joining SenGenuity, he was the Chief Executive Officer of a young high-tech company, BiODE, responsible for the coordination and direction of operations, sales, marketing, manufacturing and business development activities for viscometer sensors for multiple scalable markets and eventually led the company to an acquisition event by Dover Corporation (NYSE:DOV). He was the past Chief Technical Officer for STEAG HamaTech, Inc., a world leader in optical disc and semiconductor equipment design and manufacture. Before coming to STEAG, Kerem was Engineering Manager at Conceptronic, Inc. a leading global company which designed and manufactured capital equipment for the electronics industry. He has designed high tech and proprietary technology and products for rapid commercialization for several Fortune 500 companies, is a holder of several patents and has presented and published in numerous conferences, trade magazines and peer reviewed journals. 

He is currently the Chair and member of the Board of Directors of RateElert (www.rateelert.com).  He also serves as advisor and mentor for the Top Gun program (www.topgunmaine.biz), a premier entrepreneurship boot-camp in Maine.

Until recently, he also served on the Board of Directors for Maine Center for Enterprise Development (www.mced.biz), and was the Chair of Board for the University of Southern Maine College of Science, Technology and Health (http://usm.maine.edu/csth/). Additionally he was on the Board of Lift360 (www.lift360.org), an organization dedicated to improving the operational and leadership capabilities of the non-profit sector. He has also served on the boards of several other non-profits (notably International Child Enrichment Program (www.icepkidsplay.org) and is also the founder of an event targeted to encourage entrepreneurship for high school and college students in Maine (www.createmaine.com). 

 Mr. Durdag is also a published essayist, poet (www.ireakt.com) and past editor of poetry magazines.  He received his Bachelor of Science from St. John’s University (MN) and Master in Mechanical Engineering from University of New Hampshire

Kathleen Hagan








Kathleen Hagan is President of Hagan & Company, an international marketing and management consulting firm. She has thirty five years of leadership experience in international marketing and business development, entrepreneurship and technology commercialization, government and higher education. Her current areas of industry focus include:  healthcare technology, medical devices, life sciences, software, cyber-security, analytical instruments and robotics.

Kathleen has held a number of leadership positions in entrepreneurial management including: Director of the Northern Ireland Technology and Development Center, a venture center for innovative high technology companies from Northern Ireland; Director of International Programs at Babson College; and Director of the MIT Enterprise Forum, an entrepreneurship education program of the Massachusetts Institute of Technology delivered in 25 cities in the U.S. and around the world.

She has a broad background in international business and government affairs. She was Director of Foreign Trade for the Massachusetts Port Authority responsible for the Authority’s overseas offices in London and Tokyo and programs to develop international business for New England companies in Europe, Asia, Latin America, and Africa.  She was also District Office Director for former U.S. Senator Edward W. Brooke in charge of the Senate Massachusetts office handling a full range of policy issues including economic development and federal regulation of business.

 Kathleen holds an MBA cum laude from Boston University and a BA from Trinity College, Washington, D.C.  She has taught Global Marketing Strategy at Babson College and at Northeastern University. She is an author and speaker on international topics and has testified before Congress on small business and international trade issues. She is also a robotics industry analyst and wrote the first comprehensive industry report on the Massachusetts robotics sector. Ms. Hagan sits on several corporate, professional and non-profit boards.

  

 
Heather Keith 






 


Heather Keith has 20 years of medical device marketing and sales experience, as well as several years of manufacturing and regulatory experience.  She developed a national sales team for a start-up medical device company and grew sales from zero revenues to $13 million in less than three years.  Heather has managed product lines, marketing teams and sales teams.  She has worked as a strategy and implementation consultant for numerous product and service-based medical device companies focusing on sales strategies, market development, product extension opportunities and company acquisition decisions.  She has double bachelor degrees in Biology and Business Administration with a Chemistry minor and received her MBA from Boston University Metropolitan College.

 

Fletcher Kittredge






 

Fletcher Kittredge is the CEO and founder of GWI in Biddeford, Maine.  Founded in 1994, GWI is a telecommunications company specializing in providing gigabit fiber networks and cloud telephone solutions to Maine.  Fletcher is a graduate of Colby College and Harvard University. He serves on the board of the Maine Center for Public Interest Reporting, the Maine Center for Entrepreneurial Development, and is Chairman of the ConnectME Authority Advisory Board.


In 2011, Fletcher was named Large Business Leader of the Year by Mainebiz magazine and has led GWI to be recognized by INC. Magazine as one of the nation’s fastest growing companies five times. 


Jacques Santucci








Jacques has worked for international groups in Europe and in the USA and held leadership positions in the entertainment, tourism, financial services and technology industries. He began his career in audit at Ernst &Young and then at Universal Pictures in Paris, France.

Since moving to Maine in 1999, Jacques has held several executive positions, turning around the newly acquired US operations of an international yacht charter company or serving as CFO of a multi-entity private capital firm that he helped recapitalize. He recently participated in the sale of the US business unit of a Canada-based IT services firm. Over the past few years, he has participated in a number of turnarounds, reorganizations and sale of companies in Maine.  He was also involved in a number of bank engagements in ME and VT.

He has experience in the areas of turnarounds, reorganization, due diligence, exit strategy, financial systems, planning and analysis, sales and marketing strategy and overall business management.

Jacques holds an MBA from EDHEC School of Management in Lille, France with a concentration in Finance.  In the Portland area, he participates to the community life as host and producer of a weekly show on WMPG, the Greater Portland community radio, as well as participating in several non-profit organizations as a board member. He is a board member of the Center for Wellness Leadership and a Trustee of the Circus Conservatory of America.

 
Janet Yancey-Wrona, PhD








Janet is a pragmatic life sciences leader focused on developing and implementing effective strategies to drive product commercialization and increase sales. She has served in executive, marketing and business development roles at companies such as COO with AIKO Biotechnology, Maine Manufacturing LLC and most recently CEO for Bar Harbor BioTechnology. She served the State of Maine overseeing the investment of more than $40 million for innovative projects and drafting the State’s Science and Technology Action Plan. Her scientific background provides an analytical perspective that combines with a collaborative approach to engage and maximize value for all stakeholders.





Accelerating Technology from Concept to Market